CD79A and Alzheimer disease: Furthermore, we noted higher, albeit not significantly, IgA levels in APOEε4 non-carrying AD patients compared to APOEε4-carrying (120.26 ± 45.69 vs 75.43 ± 46.21 mg/ml, respectively) (p = 0.093).